Research ArticleOriginal Article
Open Access

Severe subtype of alopecia areata is highly associated with thyroid autoimmunity

Ghada A. Bin Saif
Saudi Medical Journal June 2016, 37 (6) 656-661; DOI: https://doi.org/10.15537/smj.2016.6.13777

References

  1. ↵
    1. Alkhalifah A,
    2. Alsantali A,
    3. Wang E,
    4. McElwee KJ,
    5. Shapiro J
    (2010) Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 62:177–188.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Gilhar A,
    2. Etzioni A,
    3. Paus R
    (2012) Alopecia areata. N Engl J Med 366:1515–1525.
    OpenUrlCrossRefPubMedWeb of Science
    1. Bertolini M,
    2. Gilhar A,
    3. Paus R
    (2012) Alopecia areata as a model for T cell-dependent autoimmune diseases. Exp Dermatol 21:477–479.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Huang KP,
    2. Mullangi S,
    3. Guo Y,
    4. Qureshi AA
    (2013) Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol 149:789–794.
    OpenUrl
  5. ↵
    1. Puavilai S,
    2. Puavilai G,
    3. Charuwichitratana S,
    4. Sakuntabhai A,
    5. Sriprachya-Anunt S
    (1994) Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol 33:632–633.
    OpenUrlPubMed
  6. ↵
    1. Rahnama Z,
    2. Farajzadeh S,
    3. Mohamamdi S,
    4. Masoudi MA
    (2014) Prevalence of thyroid disorders in patients with alopecia areata. J Pak Assoc Derma 24:246–250.
    OpenUrl
  7. ↵
    1. Kavak A,
    2. Baykal C,
    3. Ozarmağan G,
    4. Akar U
    (2000) HLA in alopecia areata. Int J Dermatol 39:589–592.
    OpenUrlPubMed
  8. ↵
    1. Medici M,
    2. Porcu E,
    3. Pistis G,
    4. Teumer A,
    5. Brown SJ,
    6. Jensen RA,
    7. et al.
    (2014) Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS Genet 10:e1004123.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Khan FA,
    2. Al-Jameil N,
    3. Khan MF,
    4. Al-Rashid M,
    5. Tabassum H
    (2015) Thyroid dysfunction: an autoimmune aspect. Int J Clin Exp Med 8:6677–6681.
    OpenUrl
  10. ↵
    1. Unuane D,
    2. Velkeniers B,
    3. Anckaert E,
    4. Schiettecatte J,
    5. Tournaye H,
    6. Haentjens P,
    7. et al.
    (2013) Thyroglobulin autoantibodies: is there any added value in the detection of thyroid auto-immunity in women consulting for fertility treatment? Thyroid 23:1022–1028.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Hollowell JG,
    2. Staehling NW,
    3. Flanders WD,
    4. Hannon WH,
    5. Gunter EW,
    6. Spencer CA,
    7. et al.
    (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Strieder TG,
    2. Prummel MF,
    3. Tijssen JG,
    4. Endert E,
    5. Wiersinga WM
    (2003) Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf) 59:396–401.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Al-Khawajah M
    (1991) Alopecia areata and associated diseases in Saudi patients. Ann Saudi Med 11:651–654.
    OpenUrlPubMed
    1. Serarslan G,
    2. Savaş N,
    3. Yenin JZ
    (2012) Is atopy and autoimmunity more prevalent in patients with alopecia areata?A comparative study. J Eur Acad Dermatol Venereol 26:720–723.
    OpenUrlPubMed
  15. ↵
    1. Cunliffe WJ,
    2. Hall R,
    3. Stevenson CJ,
    4. Weightman D
    (1969) Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol 81:877–881.
    OpenUrlPubMedWeb of Science
  16. ↵
    1. Kasumagić-Halilović E
    (2008) Thyroid autoimmunity in patients with alopecia areata. Acta Dermatovenerol Croat 16:123–125.
    OpenUrlPubMed
  17. ↵
    1. Seyrafi H,
    2. Akhiani M,
    3. Abbasi H,
    4. Mirpour S,
    5. Gholamrezanezhad A
    (2005) Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients. BMC Dermatol 5:11.
    OpenUrlPubMed
    1. Baars MP,
    2. Greebe RJ,
    3. Pop VJ
    (2013) High prevalence of thyroid peroxidase antibodies in patients with alopecia areata. J Eur Acad Dermatol Venereol 27:137–139.
    OpenUrl
    1. Kasumagić-Halilović E,
    2. Prohić A,
    3. Ovčina-Kurtović N,
    4. Čavaljuga S
    (2010) Structural and functional abnormalities of the thyroid gland in patients with alopecia areata. Medicinski zurnal 16:52–54.
    OpenUrl
    1. Chu SY,
    2. Chen YJ,
    3. Tseng WC,
    4. Lin MW,
    5. Chen TJ,
    6. Hwang CY,
    7. et al.
    (2011) Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol 65:949–956.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Noso S,
    2. Park C,
    3. Babaya N,
    4. Hiromine Y,
    5. Harada T,
    6. Ito H,
    7. et al.
    (2015) Organ specificity in auto-immune diseases: thyroid and islet autoimmunity in alopecia areata. J Clin Endocrinol Metab 100:1976–1983.
    OpenUrl
  22. ↵
    1. Goh C,
    2. Finkel M,
    3. Christos PJ,
    4. Sinha AA
    (2006) Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family histo-ry. J Eur Acad Dermatol Venereol 20:1055–1060.
    OpenUrlPubMed
    1. Tan E,
    2. Tay YK,
    3. Goh CL,
    4. Chin Giam Y
    (2002) The pattern and profile of alopecia areata in Singapore-a study of 219 Asians. Int J Dermatol 41:748–753.
    OpenUrlCrossRefPubMedWeb of Science
    1. Green J,
    2. Sinclair RD
    (2000) Genetics of alopecia areata. Australas J Dermatol 41:213–218.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Sharma VK,
    2. Dawn G,
    3. Kumar B
    (1996) Profile of alopecia areata in northern India. Int J Dermatol 35:22–27.
    OpenUrlPubMedWeb of Science
  26. ↵
    1. Bakry OA,
    2. Basha MA,
    3. El Shafiee MK,
    4. Shehata WA
    (2014) Thyroid disorders associated with alopecia areata in egyptian patients. Indian J Dermatol 59:49–55.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Seirafi H,
    2. Ehsani A,
    3. Hosseini M,
    4. Samavati B,
    5. Gholamali F,
    6. Noormohammadpour P
    (2013) Comparison of thyroid function tests in alopecia totalis and universalis with control group. Tehran Univ Med J 71:238–243.
    OpenUrl
  28. ↵
    1. Barahmani N,
    2. Schabath MB,
    3. Duvic M
    (2009) National Alopecia Areata Registry.History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol 61:581–591.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Colombe BW,
    2. Lou CD,
    3. Price VH
    (1999) The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J Investig Dermatol Symp Proc 4:216–219.
    OpenUrlPubMedWeb of Science
    1. Lee S,
    2. Paik SH,
    3. Kim HJ,
    4. Ryu HH,
    5. Cha S,
    6. Jo SJ,
    7. et al.
    (2013) Exomic sequencing of immune-related genes reveals novel candidate variants associated with alopecia universalis. PLoS One 8:e53613.
    OpenUrl
    1. Alfadhli S,
    2. Nanda A
    (2014) Genetic analysis of interleukin-1 receptor antagonist and interleukin-1ßsingle-nucleotide polymorphisms C-511T and C+3953T in alopecia areata: susceptibility and severity association. Clin Exp Med 14:197–202.
    OpenUrl
  32. ↵
    1. Redler S,
    2. Albert F,
    3. Brockschmidt FF,
    4. Herold C,
    5. Hanneken S,
    6. Eigelshoven S,
    7. et al.
    (2012) Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severe alopecia areata. Br J Dermatol 167:1360–1365.
    OpenUrl
  33. ↵
    1. Bumbacea RS,
    2. Popa LG,
    3. Orzan OA,
    4. Voiculescu VM,
    5. Giurcaneanu C
    (2014) Clinical and therapeutic implications of the association between chronic urticaria and autoimmune thyroiditis. Acta Endocrinologica 10:595–604.
    OpenUrl
  34. ↵
    1. Padberg S,
    2. Heller K,
    3. Usadel KH,
    4. Schumm Draeger PM
    (2001) One-year prophylactic treatment of euthyroid Hashimoto’s thyroiditis patients with levothyroxine: is there a benefit? Thyroid 11:249–255.
    OpenUrlCrossRefPubMedWeb of Science
    1. Schmidt M,
    2. Voell M,
    3. Rahlff I,
    4. Dietlein M,
    5. Kobe C,
    6. Faust M,
    7. et al.
    (2008) Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto’s thyroiditis) treated with levothyroxine. Thyroid 18:755–760.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Aksoy DY,
    2. Kerimoglu U,
    3. Okur H,
    4. Canpinar H,
    5. Karaağaoğlu E,
    6. Yetgin S,
    7. et al.
    (2005) Effects of prophylactic thyroid hormone replacement in euthyroid Hashimoto’s thyroiditis. Endocr J 52:337–343.
    OpenUrlCrossRefPubMedWeb of Science
  37. ↵
    1. Fan Y,
    2. Xu S,
    3. Zhang H,
    4. Cao W,
    5. Wang K,
    6. Chen G,
    7. et al.
    (2014) Selenium supplementation for autoimmune thyroiditis: a systematic review and meta-analysis. Int J Endocrinol 2014:904573.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section